Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review.

Chronic lymphocytic leukemia (CLL) is a disorder with multiple defects leading to an increased susceptibility to infection. Hypogammaglobulinemia is present in about 20% to 70% of patients with CLL. Intravenous immunoglobulin (IVIG) supplementation (400 mg/kg body weight every 3 weeks) prevented bac...

詳細記述

書誌詳細
主要な著者: Dicato, M, Chapel, H, Gamm, H, Lee, M, Ries, F, Marichal, S, Wirth, C, Griffith, H, Brennan, V
フォーマット: Conference item
出版事項: 1991